HPV vaccination could eliminate cervical cancer, study suggests

A meta-analysis including 60 million individuals in high-income countries has discovered significant decreases in HPV infections, anogenital wart diagnoses and precancerous cervical lesions (CIN2+) over the 8–9 years following HPV vaccination. The results, published in The Lancet, provide strong real-world evidence that the vaccination can prevent cervical cancer, backing the recent WHO position that multiple age groups should be vaccinated (as opposed to a single cohort) when introducing the vaccine. Moreover, the analysis shows the greater and faster impact and herd effects in countries with both multi-cohort vaccination and high vaccination coverage. Author, Marc Brisson from Laval University (Quebec, Canada) commented: “The landscape...